التفاصيل البيبلوغرافية
| العنوان: |
Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report |
| المؤلفون: |
Chan, Steven M, George, Tracy, Cherry, Athena M, Medeiros, Bruno C |
| بيانات النشر: |
BioMed Central Ltd. |
| سنة النشر: |
2009 |
| المجموعة: |
BioMed Central |
| الوصف: |
Background Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder considered to be a variant of multiple myeloma. It is an aggressive disease with a poor clinical response to standard chemotherapeutic agents. Case presentation A novel regimen consisting of bortezomib, doxorubicin, and dexamethasone is currently under active evaluation for the treatment of multiple myeloma. We employed this combination as front-line chemoinduction therapy for a case of primary PCL. Conclusion Complete remission was achieved with rapid normalization of hematologic parameters. The combination of bortezomib, doxorubicin and dexamethasone demonstrates promise in the treatment of PCL. |
| نوع الوثيقة: |
report |
| اللغة: |
English |
| العلاقة: |
http://www.casesjournal.com/content/2/1/121Test |
| الإتاحة: |
http://www.casesjournal.com/content/2/1/121Test |
| حقوق: |
Copyright 2009 Chan et al; licensee BioMed Central Ltd. |
| رقم الانضمام: |
edsbas.83FC6E14 |
| قاعدة البيانات: |
BASE |
